CDIO
Income statement / Annual
Last year (2025), Cardio Diagnostics Holdings Inc's total revenue was $14.83 K,
a decrease of 57.51% from the previous year.
In 2025, Cardio Diagnostics Holdings Inc's net income was -$6.50 M.
See Cardio Diagnostics Holdings Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$14.83 K |
$34.89 K |
$17.07 K |
$950.00 |
$901.00 |
$0.00 |
| Cost of Revenue |
$398.13 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$383.30 K
|
$34.89 K
|
$17.07 K
|
$950.00
|
$901.00
|
$0.00
|
| Gross Profit Ratio |
-25.86
|
1
|
1
|
1
|
1
|
0
|
| Research and Development Expenses |
$641.21 K
|
$29.13 K
|
$145.18 K
|
$40.45 K
|
$31.47 K
|
$1.50 K
|
| General & Administrative Expenses |
$0.00
|
$8.17 M
|
$6.94 M
|
$4.40 M
|
$470.56 K
|
$591.52 K
|
| Selling & Marketing Expenses |
$766.89 K
|
$182.45 K
|
$158.51 K
|
$92.70 K
|
$103.32 K
|
$5.48 K
|
| Selling, General & Administrative Expenses |
$766.89 K
|
$8.35 M
|
$7.10 M
|
$4.49 M
|
$573.88 K
|
$597.00 K
|
| Other Expenses |
$4.69 M
|
$19.74 K
|
$19.18 K
|
$16.00 K
|
$16.00 K
|
$10.67 K
|
| Operating Expenses |
$6.10 M
|
$8.40 M
|
$7.26 M
|
$4.55 M
|
$621.35 K
|
$609.16 K
|
| Cost And Expenses |
$6.50 M
|
$8.40 M
|
$7.26 M
|
$4.55 M
|
$621.35 K
|
$609.16 K
|
| Interest Income |
$712.00
|
$1.06 K
|
$1.07 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$14.80 K
|
$18.64 K
|
$6.74 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$398.13 K
|
$276.35 K
|
$111.62 K
|
$16.00 K
|
$16.00 K
|
$10.67 K
|
| EBITDA |
-$6.09 M |
-$8.09 M |
-$1.53 M |
-$4.64 M |
-$604.45 K |
-$598.50 K |
| EBITDA Ratio |
-410.52
|
-231.83
|
-89.67
|
-4889.46
|
-670.86
|
0
|
| Operating Income Ratio |
-437.37
|
-239.78
|
-424.4
|
-4787.84
|
-688.62
|
0
|
| Total Other Income/Expenses Net |
-$14.09 K
|
-$17.58 K
|
-$1.13 M
|
-$112.53 K
|
$0.00
|
$4.00 K
|
| Income Before Tax |
-$6.50 M
|
-$8.38 M
|
-$8.38 M
|
-$4.66 M
|
-$620.45 K
|
-$605.16 K
|
| Income Before Tax Ratio |
-438.32
|
-240.28
|
-490.88
|
-4906.3
|
-688.62
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$6.50 M
|
-$8.38 M
|
-$8.38 M
|
-$4.66 M
|
-$620.45 K
|
-$605.16 K
|
| Net Income Ratio |
-438.32
|
-240.28
|
-490.88
|
-4906.3
|
-688.62
|
0
|
| EPS |
-3.71 |
-9.3 |
-19.8 |
-45.3 |
-1.96 |
-0.0636 |
| EPS Diluted |
-3.71 |
-9.3 |
-19.8 |
-45.3 |
-1.96 |
-0.0636 |
| Weighted Average Shares Out |
$1.75 M
|
$26.89 M
|
$422.84 K
|
$3.09 M
|
$317.16 K
|
$9.52 M
|
| Weighted Average Shares Out Diluted |
$1.75 M
|
$26.89 M
|
$422.84 K
|
$3.09 M
|
$317.16 K
|
$9.52 M
|
| Link |
|
|
|
|
|
|
